|Year : 2019 | Volume
| Issue : 1 | Page : 27-33
Efficacy of Virechana (therapeutic purgation) followed by Go-Ghrita (cow ghee) in the management of Ksheena Shukra (oligozoospermia): A clinical study
Jitendra Nathabhai Varsakiya1, Mandip Goyal2, Anup Thakar3, Shilpa Donga4, Divyarani Kathad5
1 Department of Kayachikitsa, Chaudhary Brahm Prakash Ayurved Charak Sansthan, New Delhi, India
2 Department of Kayachikitsa, IPGT and RA, Gujarat Ayurved University, Jamnagar, Gujarat, India
3 Department of Panchakarma, IPGT and RA, Gujarat Ayurved University, Jamnagar, Gujarat, India
4 Department of PTSR, IPGT and RA, Gujarat Ayurved University, Jamnagar, Gujarat, India
5 Department of Shalakya Tantra, Akhandanand Ayurved College, Ahmedabad, Gujarat, India
|Date of Web Publication||21-Nov-2019|
Jitendra Nathabhai Varsakiya
Department of Kayachikitsa, Chaudhary Brahm Prakash Ayurved Charak Sansthan, Khera Dabar, Najafgarh, New Delhi - 110 073
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Fertility is affected by many different cultural, environmental and socioeconomic factors, especially in developing countries where poverty and infections are common place. Infertility is the inability of a sexually active, noncontracepting couple to achieve spontaneous pregnancy in 1 year. Shodhana (biopurificatory) procedures are indicated before the administration of Vajikarana (aphrodisiac) drugs, especially Virechana Karma (therapeutic purgation) is indicated in the cases of vitiation of Shukra (seminal parameters). Go-Ghrita(cow ghee) is a rejuvenator and aphrodisiac. Maximum preparations for the diseases of Shukra and reproductive system are prepared in Go-Ghrita and reported to be useful in the management of infertility. Aim: The present clinical study aimed to evaluate the clinical efficacy of Go-Ghrita administered after performing Virechana Karma in the management of Ksheena Shukra (oligozoospermia). Materials and Methods: Eligible male participants from the age group of 21 to 40 years, with sperm count of <15 million/ml, received cow ghee for 8 weeks in the dose of 10 g, after undergoing Virechana Karma with Haritakyadi Yoga. Percentage changes in the semen parameters and associated symptoms of Ksheena Shukra in comparison to baseline were the primary outcomes measured. Results: Go-Ghrita administered after Virechana provided 80.92% increase in total sperm count, 41.78% increase in sperm motility, 12.58% increase in normal form of sperm, 41.69% decrease in abnormal forms, and increase in semen volume by 45.22%. Conclusion: Overall assessment of the therapy showed that administration of cow ghee after performing Virechana provided statistically highly significant improvement on seminal parameters.
Keywords: Go-Ghrita, Haritakyadi Yoga, Ksheena Shukra, oligozoospermia, Virechana
|How to cite this article:|
Varsakiya JN, Goyal M, Thakar A, Donga S, Kathad D. Efficacy of Virechana (therapeutic purgation) followed by Go-Ghrita (cow ghee) in the management of Ksheena Shukra (oligozoospermia): A clinical study. AYU 2019;40:27-33
|How to cite this URL:|
Varsakiya JN, Goyal M, Thakar A, Donga S, Kathad D. Efficacy of Virechana (therapeutic purgation) followed by Go-Ghrita (cow ghee) in the management of Ksheena Shukra (oligozoospermia): A clinical study. AYU [serial online] 2019 [cited 2020 Apr 5];40:27-33. Available from: http://www.ayujournal.org/text.asp?2019/40/1/27/271428
| Introduction|| |
Infertility as a medical and social problem has acquired global dimension, and its incidence is supposed to be increasing day by day every decade. Nature is always doing better for all living being; but due to the present lifestyle, there has been a drastic change in day-to-day activities including lifestyle, food habits, sexual life, environmental pollution, industrial and occupational hazards and these changes have adverse effect on Shukra Dhatu which leads to infertility. Infertility affects 10% of couples, usually as a result of asymptomatic infection. Poverty, nutrition and pollution are problems that must also be tackled. One such factor is the role of low sperm count in male infertility and its management. The most cost-effective approach to solve the infertility problems is prevention and education. Infertility is defined as inability to conceive after a year of sexual intercourse without the use of contraceptives. A male contributory factor is involved in approximately half of these cases, but most of the causes for reduced semen quality and other disturbances of male reproductive function are unknown. Oligozoospermia is termed as Ksheena Shukra in Ayurvedic text which indicates low volume and less number of spermatozoa in seminal fluid.
The principle of treatment for depletion of tissue (Dhatu Kshaya) is to administer the drugs, which are having the same qualities of that Dhatu. Drugs having properties like Madhura(sweet), Sheeta(cold) and Snigdha(unctuous) are effective in enhancing the quality and quantity of Shukra Dhatu.Ghrita also possess similar properties, that is Madhura, Sheeta and Snigdha, and thus helps to increase semen parameters. Ghrita is best among all Sneha used internally and helps for digestion, absorption and delivery of drugs processed in it, to a target organ system.
Further, it is mentioned in Ayurveda texts that it is essential to perform Shodhana (biopurification) procedure before administering the Vajikarana (aphrodisiac) drugs. Only then Brimhana (nourising) and Balya (gives strength/power/stemina) effect of Vajikarana are achieved. It is clearly stated that without Shodhana, Vajikarana treatment is of no use. Shodhana procedures mainly Virechana are described for the management of Shukra Dosha.
Aims and objectives
The objective was to evaluate the efficacy of Virechana followed by oral administration of Go-Ghrita in the management of Ksheena Shukra (oligozoospermia).
| Materials and Methods|| |
For the clinical study, 42 male patients suffering from primary or secondary infertility for >1 year and having sperm count <15 million/ml and willing to participate in the clinical trial were selected irrespective of religion and caste from the outpatient department of Kayachikitsa or referred from Prasuti Tantra and Streeroga department of IPGT&RA hospital. Permission was obtained from the Institutional Ethics Committee of the institute; vide Ref-PGT/7/-A/ethics/2015-16/2675, dated: December 11, 2015, and the study was also registered in Clinical Trials Registry-India (CTRI) (vide CTRI//20164/01/006559). Informed consent was obtained from all the participants before including them in the present study.
Male patients with a age group of 21–40 years having sperm count <15 million/ml and eligible for the procedure of Virechana were included for the present clinical trial.
Male patient of age below 21 and above 40 years having sperm count >15 million/ml, patient of azoospermia and aspermia or suffering from varicocele, accessory sex gland infection, sexually transmitted diseases and severe systemic diseases were excluded from the study. Patients who had genetic disorders such as Klinefelter's syndrome or taking treatment for major psychiatric illness, history of previous medications, and trauma, leading to oligozoospermia and the patient not eligible for Virechana were also excluded from the present clinical trial.
Semen analysis was carried out on registering the patients, which was taken as the baseline and thereafter, it was repeated after Samsarjana Krama (dietary regimen after Virechana) and on the 8 weeks of the oral treatment with Go-Ghrita. Serum follicle-stimulating hormone (FSH), serum luteinizing hormone (LH) and serum testosterone were taken as biomarkers and these tests were done before and after the treatment in selected patients due to budgetary provision. Routine hematological and urine examination were carried out to assess the status of the patients and to exclude other pathologies. In suspected cases, ultrasonography of abdomen and pelvis was done to rule out hydrocele, varicocele and other pathologies that are secondary cause of oligoospermia, before including the patients in present clinical trial.
Before administration of Go-Ghrita, Virechana Karma was performed. The details of drugs used for Virechana Karma are mentioned in [Table 1]. For the present clinical trial, Go-Ghrita, was procured from Khadi Gramodyog, Jamnagar and authenticated in the pharmacognosy Laboratory of the institute. All other drugs used in the Virechana process were procured from pharmacy of Gujarat Ayurved University, Jamnagar.
Method of Virechana Karma
Before administration of Go-Ghrita, all the registered patients were given Virechana. For this purpose, patients who met inclusion criteria and gave consent for the Virechana were administered Trikatu Churna for the first 3 days for Deepana and Pachana (stimulation of digestion) in the dose of 2 g twice in a day with lukewarm water after meal. On the 4th day, after assessing the status of the patients, Cow Ghrita in the dose of 40 ml was given in the early morning on empty stomach with lukewarm water. The patients were observed for Sneha Jeerna Lakhshana (proper digestion of Ghrita) and accordingly for the next 5–7 days, the dose of Ghrita was given in increasing pattern till the patients achieved proper Snehana (internal oleation) features. After completion of internal Snehana for the next 3 days, whole-body massage with Bala Taila along with Vashpa Swedana was done daily once in the morning. During this period, patients were kept on a normal diet with precautions, to avoid excessive oil, or heavy food items. On the day of Virechana, after massage and fomentation in the morning, Virechana Yoga of Haritakyadi Yoga was given.
Method of preparation of Haritakyadi Yoga
For the preparation of Haritakyadi Yoga, 18 g (each in same amount) of fine powder of Haritaki (Terminalia chebula Retz.), Saindhava (Rock Salt), Amalaki (Emblica officinalis Gaertn.), Vacha (Acorus calamus Linn.), Vidanga (Embelia ribes Burm. F.), Rajani (Curcuma longa Linn.), Pippali (Piper longum Linn.) and Shunthi (Zingiber officinale Rosc.) was taken. About 2 g of Guda (jaggery) was added to it. To this half glass of water was added and heated until it was lukewarm. This was given to patients on empty stomach.
Thereafter, according to the type of Shuddhi, at the end of Virechana procedure, 3, 5 and 7 days of post-Virechana dietary regimen for revival were advised which included Peya (thin gruel of rice), Vilepi (thick gruel of rice), Akrita Yusha (nonprocessed soup of vegetables/pulses) and Krita Yusha (processed with Ghrita, salt and pepper, soup of vegetables/pulses) in a sequential pattern.
After completion of Virechana, Go-Ghrita was administered for 8 weeks in the dose 10 gm twice a day after meal with a cup of milk and patients were asked to report fortnightly and on every visit, the details regarding the status were recorded.
Criteria for assessment
The efficacy of the treatment was assessed on the basis of improvement in the subjective as well as objective parameters. For the subjective parameters, an appropriate scoring pattern was adopted for parameters such as sexual desire, erection, rigidity, performance anxiety, ejaculation, orgasm, overall satisfaction, erectile function and post act-exhaustion. The scoring pattern assessed before and after the completion of treatment is shown in [Appendix 1].
Improvement in the semenogram was observed, especially on the total sperm count. Changes in serum FSH, serum LH and serum testosterone were also considered for assessment and they were assessed in comparison to the baseline score in all patients.
General data was subjected to suitable statistical analysis such as descriptive statistics for demographic data, Wilcoxon signed-rank test for nonparametric paired data and paired t-test for quantitative parametric paired data.
After preparing the master chart of all the required data in the Microsoft Excel worksheet, statistical calculations were made with the help of Sigma Stat 3.5 software and In Stat 3 software product software by Aspire software international. The results were interpreted as significant (P < 0.05), highly significant (P < 0.01), very highly significant (P < 0.001) and insignificant (P > 0.05).
Observation on demographic data
A total of 42 male patients of oligozoospermia (Ksheena Shukra) were registered for the present study, of which 38 patients completed the full course of treatment, and four patients dropped out as they did not timely report for the follow-up. In the study, the maximum number of patients (47.61%) were in the age group of 21–30 years, belonged to the Hindu religion (95.23%) and 47.61% had secondary education. Nearly, 61.90% of the patients were from urban area and were belonging to poor socioeconomic class (59.52%) and 45.23% of them were laborer by occupation.
Around 53.44% of the patients were doing heavy physical exertion, 59.52% of the patients in the present trial had Vishama Agni (irregular digestive process), 50% of patients had irregular dietary habits, 78.57% of the patients had the habit of taking frequent hot water bath and 95.32% of the patients were wearing tight undergarment. About 47.61% of the patients had the habit of chewing tobacco followed by 30.95% having addiction of smoking cigarette, 38.09% of the patients were having reduced and disturbed sleep and 52.38% of the patients were suffering from negative psychological emotions such as stress and worry (35.71).
The 47.61% of the patients had Vata-Pitta Prakriti and were having Madhyama Bala. About 95.23% of the patients were in the habit of taking Lavana (salt) predominant diet. Almost 78.79% of the patients had history of consumption of spicy food, 97.61% of the patients had primary infertility, while 2.38% of the patients had secondary infertility, 78.49% of the patients reported exertion during intercourse, followed by 26.88% of patients with less motivation, 78.57% of the patients complaint of loss of sexual desire, 88.90% of patients with general debility and 50% of the patients had low semen volume and premature ejaculation.
| Results|| |
Effect on seminal parameters
Go-Ghrita administered after Virechana (medicated purgartion) provided increase of 80.92%, on total sperm count, 41.78% increase in sperm motility, 12.58% increase in normal form of total sperm, 41.69% decrease in abnormal forms, and increase in semen volume by 45.22%. Further analysis revealed when the effect was assessed for the period of before treatment and after Samsarjan Krama i.e. after the completion of Virechana procedure 68.87% increase in total sperm count was found 37.76% increase in total sperm count was found when the effect was assessed for the period between Samsarjana Karma and after the treatment i.e. eight weeks of treatment with oral administration of Go-Ghrita.
In sperm motility, before treatment and after Samsarjan Krama, 38.55% increase was found. When assessed between after completion of Samsarjana Krama and after completion of treatment, 15.09% increase in sperm motility was found. Before treatment and after, assessment of Samsarjan Krama revealed that cow Ghrita provided 9.85% increase in normal sperm count. After Samsarjana Krama and after treatment, the therapy provided 4.60% increase in normal sperm count.
Similarly, the analysis of the result showed that during before treatment and Samsarjan Krama decrease in abnormal form was 27.88%. After Samsarjana Krama and after completion of treatment provided decrease in abnormal form of sperm of 24.85% [Table 2].
Effect on hormones
Go-Ghrita administered after Virechana provided 17.38% increase in serum FSH, 26.63% increase in serum LH value and 25.84% increase in serum testosterone value. All these changes reported on hormones were statistically highly insignificant [Table 3].
Effect on hematological parameters
There was no statistically significant changes (P > 0.05) in the hematological parameters such as hemoglobin, total red blood cell count, total leukocyte count, differential count and biochemical parameters such as fasting blood sugar, serum cholesterol, serum triglyceride, serum creatinine, blood urea and serum glutamic pyruvic transaminase. Although there is a change from pretest to posttest mean value of above parameters it was within the normal limits. This proves that there was no adverse effect of the treatment.
Effect of therapy on subjective criteria
Go-Ghrita administered after Virechana (medicated purgation) provided statistically highly significant (P < 0.001) result on generalized debility (83.33%), sexual weakness (16.66%), sexual desire (78.02%), erectile dysfunction (75.71%), erectile rigidity (65.15%), orgasm function (72.72%), increase in overall satisfaction (81.74%), frequency of coitus (57.47%) and duration of coitus (43.27%) and ejaculatory function (57.47%) was found.
Overall effect of therapy
Assessment of overall effect of the therapy revealed that Go-Ghrita administered after Virechana Karma provided excellent response in six patients (15.78%) and these patients were able to impregnate their partner. Fifteen patients (39.47%) showed marked positive response, whereas thirteen patients (34.32%) had moderate positive response and four patients (10.52%) had mild positive response.
| Discussion|| |
Infertility and problems of impaired fecundity have been a concern through ages and is also a significant clinical problem today, which affects 8%–12% of couple worldwide in addition to 30% to 40% of cases involving both male and female factors. Male factor is present in one-half of infertile couples.Go-Ghrita possess Vrishya (aphrodiasic), Rasayana (rejuvenation), Vata and Pitta pacifying effect and digestive action. It also contains Vitamin A, D, E and K. Among them, Vitamin A and E are antioxidants and are helpful in preventing oxidative injury to the body.
Shodhana procedures are to be performed before administration of Vajikarana drugs, especially Virechana Karma has been indicated in the cases of vitiated Shukra. Therefore, Virechana Karma was selected for the present study.
Previous study on oligozoospermia concluded that Virechana Karma should be performed before administration of Vajikarana drugs and better and early changes in total sperm count can be achieved by Virechana Karma. In this study, significant result in sperm count and reduction in abnormal form of sperm along with significant effect on serum LH hormone level was found.
Maximum patients in this study were from the age group of 21–30, that is, in third decade of life and had imbalanced Agni, mainly Vishamagni (digestion controlling system). Substance which can help to balance Pitta, also act on disturbed state of Agni. If Jathragni is normal, then all Dhatus and Dhatvagni (metabolism) perform properly, leading to formation of optimum Rasa and Shukra Dhatu.
Go-Ghrita administered by Nasya, helps to regulate hormonal balance at hypothalamus level. Hormonal imbalance is one of the most etiological factors of infertility. Go-Ghrita is also can bond with lipid-soluble nutrients and herbs to penetrate the lipid-based cell walls of the body. Thus, it increases the potency of certain herbs by carrying the active components to the interior of the cells, which helps to increase marrow, semen and immunity (Ojas). It alleviates Vata-Pitta Dosha which is main Dosha leading to Ksheena Shukra.Go-Ghrita also provided significant increase in STH, SFSH and S. Testaterone.
Causative factors primarily affect the hypothalamic–pituitary–gonadal axis, which results in disturbances of serum FSH, serum LH and serum testosterone and testicular damage causing reproductive failure and infertility. Hence, it is important to maintain hormones in its normal state. Concerted action of the two gonadotropins, FSH and LH are necessary for the production of male gametes in the testis. FSH and LH exert their effect by binding to plasma membrane receptors of the target cells. LH mainly functions to stimulate testosterone secretion from the Leydig cells of the testicle, while FSH stimulates Sertoli cells More Details to facilitate germ cell differentiation. Gonadotropin release is modulated by a variety of other signals, such as estradiol (a potent inhibitor of both LH and FSH release), and inhibition from the sertoli cell, which causes a selective decrease in FSH release. Decreased amount of LH production fails to initiate spermatogenesis, thus causing oligospermia due to secondary deficiency of testosterone.
Probable mode of action of Virechana and Go-Ghrita
Vajikarana drugs (aphrodisiac recipes) should be administered after purifying the body, i.e., proper Shodhana either by Vamana or Virechana. In this study, statistically significant increase in sperm count was found after the completion of Virechana Karma and hence, it is clear from the generated data that Virechana enhances the quantity level of Shukra definitely. This may be because Virechana Karma increases the bioavailability of drugs by opening channels and by improving the nutritional assimilation which may lead to increase serum LH level.
Go-Ghrita contains Vitamin A, D, E and K. Vitamin E is an anti-sterility Vitamin, Vitamin A and Vitamin E, both are antioxidant vitamin and helps to enhance spermatogenesis. Also, study has reported that vitamin D supplementation effect on circulating levels of testosterone and also its consistent effect was reported on semen quality.Go-Ghrita has Madhura (sweet), Snigdha (unctuous) and Sheeta (cold) quality and Shukra is also homologous with it. On the basis of the qualitative aspect also, Ghrita is Rasayana and useful in palliating Vata and Pitta which are the main culprit Dosha involved in Ksheena Shukra, that is, oligozoospermia.
Shodhana has direct effect on metabolism. As Shukra is a Sara of all Dhatus, if Rasa formation is not proper, then Uttarottara Dhatu (consequence tissue) will be nourished properly. By Shodhana as preoperative regimens, medicine is adequately substantiated. It also open the occluded channels in the body and thus enhances the quality and quantity of Shukra. Go-Ghrita helps in improving digestive strength by revitalizing secretion of enzymes. Go-Ghrita is easy to absorb and metabolize, as it contains low-chain fatty acids. Constipation can be cured with cow ghee. If one consumes a spoonful of Go-Ghrita mixed in lukewarm milk daily, it helps to healthy bowel habit daily, which causes to cure Apana Vayu vitiation, which is responsible for excretion of flatus, urine, stool and semen.
| Conclusion|| |
Go-Ghrita administered after Virechana Karma provides statistically highly significant increase in total sperm count, sperm motility, normal form of sperm, volume of semen and significant decrease in abnormal form of sperm. Significant increase in serum testosterone, serum FSH and serum LH indicates that the combined therapy of Virechana followed by Go-Ghrita acts through hormonal pathway to improve seminal parameters. As Go-Ghrita has provided significant result on seminal parameters, thus it can be choice of drug for the management of oligozoospermia. As Virechna Karma has also provided a significant increase in total sperm count and improved the quality of semen, it can also concluded that Virechana Karma alone is also effective in cases of oligozoospermia.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Irvine DS. Epidemiology and aetiology of male infertility. Hum Reprod 1998;13 Suppl 1:33-44.
Sheiner EK, Sheiner E, Hammel RD, Potashnik G, Carel R. Effect of occupational exposures on male fertility: Literature review. Ind Health 2003;41:55-62.
Aacharya YT, editor. Charaka Samhita of Agnivesha, Sutra Sthana. Ch. 1., Ver. 61. Reprint edition. Varanasi: Chaukhamba Surbharati Prakashan; 2008. p. 6.
Aacharya YT, editor. Charaka Samhita of Agnivesha, Chikitsa Sthana. Ch. 2., Ver. 10. Reprint edition. Varanasi: Chaukhamba Surbharati Prakashan; 2008. p. 698.
Trevor G. Cooper, Elizabeth Noonan, Sigrid von Eckardstein, Jacques Auger, H.W. Gordon Baker, Hermann M. Behre, Trine B. Haugen, Thinus Kruger, Christina Wang, Michael T. Mbizvo, Kirsten M. Vogelsong, World Health Organization reference values for human semen characteristics, Human Reproduction Update, Volume 16, Issue 3, May-June 2010, Pages 231–245, https://doi.org/10.1093/humupd/dmp048
Aacharya YT, editor. Charaka Samhita of Agnivesha, Sutra Sthana. Ch. 27., Ver. 239. Reprint edition. Varanasi: Chaukhamba Surbharati Prakashan; 2008. p. 261.
Aacharya YT, editor. Charaka Samhita of Agnivesha, Sutra Sthana. Ch. 13., Ver. 61. Reprint edition. Varanasi: Chaukhamba Surbharati Prakashan; 2008. p. 85.
Aacharya YT, editor. Charaka Samhita of Agnivesha, Sutra Sthana. Ch. 1., Ver. 10. Reprint edition. Varanasi: Chaukhamba Surbharati Prakashan; 2008. p. 27.
Aacharya YT, editor. Charaka Samhita of Agnivesha, Sutra Sthana. Ch. 1., Ver. 11. Reprint edition. Varanasi: Chaukhamba Surbharati Prakashan; 2008. p. 28.
Mehra BL. Studies on Klaibya (Male Sexual Dysfunction) and its Management with Vajikarana. Jamnagar: Department of Kayachikitasa, I.P.G.T. and R.A., Gujarat Ayurved University; 1996. P. 135.
Kumar N, Singh AK. Trends of male factor infertility, an important cause of infertility: A review of literature. J Hum Reprod Sci 2015;8:191-6.
] [Full text]
Brahmanand T, editor. Ashtang Hridaya of Vagbhata, Sutra Sthana. Ch. 5., Ver. 37-39. Reprint edition. Delhi: Chaukhambha Sanskrit Pratithan; 20159. p. 73.
Varsakiya Jitendra, Goyal Mandip, Debbarma Bhabatosh. Role of Virechana Karma In increasing sperm count in the case of oligozoospermia: An Open Labelled Clinical Trial. International Journal of Research in Ayurveda & Pharmacy 2017;8:134-138. 10.7897/2277-4343.08298.
Acharya YT, editor. Charaka Samhita of Agnivesha. Sutra Sthana. Ch. 15., Ver. 16-17. Reprint edition. Varanasi: Chaukhambha Krishnadas Academy; 2009. p. 321.
Acharya YT, editor. Charaka Samhita of Agnivesha. Sutra Sthana. Ch. 23., Ver. 11. Reprint edition. Varanasi: Chaukhamba Surbharati Prakashan; 2008. p. 1955.
Oduwole OO, Peltoketo H, Huhtaniemi IT. Role of follicle-stimulating hormone in spermatogenesis. Front Endocrinol (Lausanne) 2018;9:763.
Pitteloud N, Dwyer A. Hormonal control of spermatogenesis in men: Therapeutic aspects in hypogonadotropic hypogonadism. Ann Endocrinol 2014;75:98-100.
Acharya YT, editor. Chikitsa Sthana. In: Charaka Samhita of Agnivesha. Ch. 7., Ver. 120. Reprint edition. Varanasi: Chaukhamba Surbharati Prakashan; 2008. p. 456.
Brahmashankara M, Rupalalaji VS, editor. Purva khanda. In: Bhavaprakasha of Bhavamishra. Part. I. Ch. 6., Ver. 759. Reprint edition. Varanasi: Chaukhambha Sanskrita Bhavana, Ghrita Varga; 2015. p. 227.
[Table 1], [Table 2], [Table 3]